• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Mol Biol . MEK/ERK signaling and Bcl-2 family protein changes in influenza-infected cells with differing sulfatide levels

tetano

Editor, Senior Moderator
J Mol Biol

. 2026 Sep 23:170031.
doi: 10.1016/j.jmb.2026.170031. Online ahead of print.

MEK/ERK signaling and Bcl-2 family protein changes in influenza-infected cells with differing sulfatide levels​


Shintaro Onishi 1 , Yuki Kurebayashi 2 , Tadanobu Takahashi 2 , Naoto Haraguchi 2 , Yu Saito 2 , Anju Nishiie 2 , Yohei Tsukamoto 2 , Hideyuki Takeuchi 2 , Takuya Mori 3 , Takashi Suzuki 2

Affiliations


Abstract​


Influenza A virus (IAV) exploits host pathways to maximize progeny production. Sulfatide, a sulfated glycosphingolipid on the plasma membrane, has been implicated in enhanced influenza replication; however, the underlying host factors remain unclear. Using sulfatide-low COS7 cells, sulfatide-enriched SulCOS1 cells, and Madin-Darby canine kidney (MDCK) cells that endogenously express sulfatide, we observed higher infectious viral yields in MDCK and SulCOS1 cells than in COS7 cells, without a corresponding increase in the number of initially infected cells. IAV infection triggered time-dependent activation of mitogen-activated protein kinase (MAPK) signaling in sulfatide-enriched cells, with a prominent response in extracellular signal-regulated kinases 1 and 2 (ERK1/2). Treatment with U0126, a mitogen-activated protein kinase kinase (MEK)/ERK-pathway inhibitor, reduced viral output without a marked increase in lactate dehydrogenase (LDH) release, although ERK dependence remains unresolved. To assess mitochondrial apoptosis-related responses, we examined the pro-apoptotic BH3-only protein Bim. In sulfatide-enriched SulCOS1 cells, Bim abundance decreased during the late phase of infection, whereas Bim remained relatively stable in COS7 cells. In MDCK cells, U0126 tended to preserve Bim abundance after infection. Although caspase-3 was activated after infection, pan-caspase inhibition did not detectably reduce hemagglutination (HA) titers under the tested conditions. In addition, changes in Bcl-2 family protein abundance were observed in MDCK and SulCOS1 cells, and Bax-targeting peptides increased influenza A and B virus production in MDCK cells. Together, these data support a model in which sulfatide-associated MEK/ERK signaling, Bim-related mitochondrial checkpoint changes, and other downstream processes may collectively contribute to efficient influenza virus production.

Keywords: Bax inhibitor; ERK signaling; apoptosis; influenza A virus; sulfatide.
 
Back
Top Bottom